AF
ENTA icon

Allworth Financial’s Enanta Pharmaceuticals ENTA Stock Holding History

Allworth Financial’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.37K Buy
425
+197
+86% +$2.64K ﹤0.01% 3920
2025
Q4 		$3.6K Sell
228
-5
-2% -$64 ﹤0.01% 3889
2025
Q3 		$2.79K Buy
233
+5
+2% +$40 ﹤0.01% 3851
2025
Q2 		$1.72K Buy
+228
New +$1.37K ﹤0.01% 3773
2024
Q2 		– Sell
-86
Closed -$1.5K – 3720
2024
Q1 		$1.5K Buy
+86
New +$1.14K ﹤0.01% 2933
2023
Q4 		– Sell
-44
Closed -$492 – 3507
2023
Q3 		$492 Buy
44
+21
+91% +$338 ﹤0.01% 3047
2023
Q2 		$493 Buy
23
+13
+130% +$383 ﹤0.01% 2906
2023
Q1 		$405 Buy
+10
New +$478 ﹤0.01% 2880
2022
Q2 		– Sell
-5
Closed – – 2506
2022
Q1 		$0 Buy
+5
New +$325 ﹤0.01% 2186
2017
Q1 		– Sell
-100
Closed -$3K – 770
2016
Q4 		$3K Hold
100
– – ﹤0.01% 534
2016
Q3 		$3K Buy
+100
New +$2.32K ﹤0.01% 561

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Allworth Financial's ENTA Position: Q1 2026 in Review

Allworth Financial increased its Enanta Pharmaceuticals (ENTA) stake by 86% in Q1 2026, buying an estimated $2.64K and bringing the position to 425 shares worth $5.37K. The position accounts for ﹤0.01% of the portfolio, ranked #3920.

Allworth Financial first reported a position in ENTA in Q3 2016 and has held it in 11 quarters since. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Allworth Financial held 425 shares of Enanta Pharmaceuticals worth $5.37K as of Q1 2026.
  • Allworth Financial bought 197 Enanta Pharmaceuticals shares in Q1 2026, an estimated $2.64K.
  • Enanta Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #3920 holding.
  • Allworth Financial first reported a position in Enanta Pharmaceuticals in Q3 2016 and has held it in 11 quarters since.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.